What Triangle Insights Group does

Triangle Insights Group is a boutique strategy consulting firm focused exclusively on the life sciences industry, headquartered in Durham, North Carolina with offices in San Francisco and New York. The firm operates as a subsidiary of Valeris under the brand 'Triangle Insights Group by Valeris' following a 2026 integration, and it draws on affiliated platforms such as Policy Reporter for policy and reimbursement intelligence. Its core technology consists of analytical and advisory capabilities built on therapeutic area expertise, primary market research methodologies, claims data analysis, and proprietary frameworks — there is no proprietary software platform.

The firm offers four core service lines: Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning. It serves enterprise pharmaceutical companies, biotechnology companies, and private equity investors, delivering senior-led consulting engagements spanning commercial assessment, launch strategy (75+ launches supported), pricing and market access, due diligence (75+ M&A transactions), and new product planning (100+ pre-commercial assets supported). The firm maintains centers of excellence in Pricing & Market Access, Cell & Gene Therapy, and New Product Planning.

Triangle Insights Group generates revenue through billable consulting engagements under fixed-fee or time-and-materials models, with no subscription or SaaS products. Go-to-market relies on direct senior-led business development through professional networks, industry conferences, referrals, and inbound demand generated by a steady cadence of white papers, case studies, and blog content. The firm claims global reach across all areas of life sciences despite its U.S.-only office footprint.

Name

Triangle Insights Group

Legal name

Triangle Insights Group Incorporated

Website

https://triangleinsightsgroup.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Triangle Insights Group is a boutique life sciences strategy consulting firm serving pharmaceutical, biotech, and private equity clients with services spanning brand strategy, pricing and market access, due diligence, and new product planning, now operating as a Valeris subsidiary.

Ownership category

akta.pro rank

Product category

Life Sciences Strategy Consulting

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

Corporate Strategy Advisory (BPAHADAA), M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA)

Keywords

• Life sciences consulting
• Pharmaceutical strategy consulting
• Biotech commercialization consulting
• Pricing and market access
• Commercial due diligence

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Strategy Consulting Engagements: Triangle Insights Group generates revenue through billable consulting engagements with pharmaceutical, biotech, and private equity clients. Engagements span commercial assessment, brand strategy, pricing and market access, new product planning, and corporate strategy/due diligence. Projects are typically scoped as fixed-fee engagements or time-and-materials engagements led by senior consultants and partners. The firm does not appear to offer subscription or SaaS products.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Triangle Insights Group is a life sciences strategy consulting firm that provides strategic guidance to pharmaceutical companies, biotechnology firms, and private equity investors. Its core offerings span four service lines—Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning—covering commercial assessment, brand strategy, launch excellence, pricing and market access, payer engagement, and transaction diligence across the pharmaceutical product lifecycle.

Product overview

Triangle Insights Group is a premier strategy consulting firm offering life sciences consulting services. The company operates as a unified consulting practice providing four core service lines: Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning. These services work together to provide end-to-end strategic guidance across the pharmaceutical lifecycle, from early pipeline assessment through commercialization and lifecycle management. The firm has participated in 75+ product launches, supported 100+ pre-commercial assets, conducted 200+ commercial assessments, and completed 75+ M&A transactions. The company also publishes white papers and insights as part of its thought leadership offering.

Differentiator

Problem solved

Functional benefit

Products and services

• Brand Strategy & Commercialization Consulting service focused on strategic brand planning, positioning, message testing, competitive strategy, and launch excellence for pharmaceutical and biotech companies. The firm has participated in 75+ launches and supports demand forecasts, go-to-market models, and organizational design.
• Corporate Strategy & Due Diligence Consulting service for pharmaceutical companies and private equity investors to conduct commercial diligence for investments, including portfolio strategy, R&D prioritization, opportunity identification, growth strategy, and transaction support for M&A and licensing.
• Pricing & Market Access Consulting service providing pricing strategy, market access planning, value proposition development, and payer engagement strategies. Includes GTN forecasting, revenue preservation strategies, evidence generation benchmarking, and lifecycle management.
• New Product Planning Strategic planning consulting to help clients maximize value for new pharmaceutical products. Covers commercial assessment, target product profile development, patient journey mapping, indication strategy, evidence generation planning, and market-shaping strategies.

Quantifiable outcome

• Triangle Insights Group has participated in 75+ pharmaceutical brand launches
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Policy ReportercoreTechnology or IntegrationTriangle Insights Group collaborates closely with Policy Reporter, an affiliated platform under the Valeris parent company, to incorporate real-time policy and reimbursement intelligence into its pricing and market access consulting engagements. This partnership enables the firm to offer clients insights informed by the latest regulatory and payer developments, strengthening the accuracy and timeliness of market access strategy recommendations.
• ValeriscoreStrategic or Co-development PartnerTriangle Insights Group operates as a business unit within Valeris, a parent company that delivers integrated life sciences and pharmaceutical commercialization services. Valeris provides the broader technology, data analytics, and operational infrastructure (including Policy Reporter) that Triangle Insights Group leverages to power its consulting engagements. The firm is branded as 'Triangle Insights Group by Valeris.'

Scale indicators11 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Putnam Associates: Putnam Associates is a boutique life sciences strategy consulting firm offering commercial strategy, market access, pricing, and due diligence services to pharma and biotech clients - the closest direct competitor to Triangle Insights Group in scale, therapeutic focus, and service mix.
• Lumanity (formerly Defined Health): Lumanity is a life sciences consulting firm built around commercialization strategy, new product planning, and evidence generation. It directly competes with Triangle Insights Group for biopharma commercial assessment and launch excellence engagements.
• ZS Associates: ZS Associates is a large global consulting firm with a deeply established pharma and biotech practice spanning commercial strategy, launch, pricing/market access, and analytics - a scaled direct competitor with overlapping service lines to Triangle's four core offerings.
• Syneos Health Consulting (formerly Campbell Alliance): Syneos Health Consulting is the consulting arm of Syneos Health and traces its roots to Campbell Alliance, a leading life sciences consulting firm. It directly competes with Triangle Insights Group in biopharma commercial strategy, launch, and due diligence work.
• Charles River Associates (Life Sciences Practice): CRA's Life Sciences practice provides strategy, economics, and litigation support to pharma, biotech, and medical product clients. It is a direct competitor in commercial assessments, pricing/market access strategy, and transaction diligence.
• Health Advances: Health Advances is a boutique life sciences strategy consulting firm serving pharma, biotech, and medtech clients with commercial assessments, new product planning, and transaction due diligence - a closely comparable direct peer to Triangle Insights Group.

Broad incumbents

• IQVIA (Consulting & Analytics): IQVIA is a global life sciences services and analytics leader with a large consulting arm spanning commercial strategy, market access, and real-world evidence. It competes with Triangle Insights Group across multiple service lines as a much larger incumbent.
• Boston Consulting Group (Biopharma practice): BCG operates a top-tier global biopharma strategy practice covering commercial strategy, launch, and M&A advisory. Several Triangle Insights Group leaders previously worked at BCG, and BCG remains a significant incumbent competitor.
• McKinsey & Company (Pharma & Medical Products practice): McKinsey's Pharma & Medical Products practice provides commercial strategy, launch excellence, and corporate strategy services to the largest global pharma clients, representing a key incumbent competitor across Triangle's offering.
• Real Chemistry (formerly W2O): Real Chemistry is a healthcare-focused advisory and communications firm with acquired strategy consulting assets (formerly Boston Healthcare Associates). It competes with Triangle Insights Group in commercial diligence and market access work for life sciences clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/triangle-insights-group-llc
• Xx.com/triangleinsight

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Triangle Insights Group